From single-target to cellular niche targeting in Crohn's disease: intercepting bad communications
The mainstay of moderate to severe Crohn's disease (CD), anti-TNF treatment, shows no clinical benefit in ∼40% of patients, likely due to incomplete cellular targeting and delayed treatment institution. While single-target therapeutics have been highly effective for some CD patients, substantia...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Elsevier
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/2edd0d56275e427b91380fd2fdfcbd3a |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|